UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Randomized Phase III Placebo-Controlled Trial of Carboplatin and Paclitaxel With or Without the Vascular Disrupting Agent Vadimezan (ASA404) in Advanced Non–Small-Cell Lung Cancer

Journal of clinical oncology, 2011-08, Vol.29 (22), p.2965-2971

2011

Volltextzugriff (PDF)

Dysregulation of the endothelial nitric oxide pathway is associated with airway inflammation in COPD

Respiratory research, 2019-07, Vol.20 (1), p.156-10, Article 156

2019

Volltextzugriff (PDF)

Asthma control in patients receiving inhaled corticosteroid and long-acting beta2-agonist fixed combinations. A real-life study comparing dry powder inhalers and a pressurized metered dose inhaler extrafine formulation

BMC pulmonary medicine, 2011-07, Vol.11 (1), p.40-40, Article 40

2011

Volltextzugriff (PDF)

Airway dynamics in COPD patients by within-breath impedance tracking: effects of continuous positive airway pressure

The European respiratory journal, 2017-02, Vol.49 (2), p.1601270-1601270

2017

Volltextzugriff (PDF)

Five-year survival in patients with extensive-stage small cell lung cancer treated with atezolizumab in the Phase III IMpower133 study and the Phase III IMbrella A extension study

Lung cancer (Amsterdam, Netherlands), 2024-10, Vol.196, p.107924, Article 107924

2024

Volltextzugriff (PDF)

Durvalumab plus platinum–etoposide versus platinum–etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): a randomised, controlled, open-label, phase 3 trial

The Lancet (British edition), 2019-11, Vol.394 (10212), p.1929-1939

2019

Volltextzugriff (PDF)

Effect of COPD on Inflammation, Lymphoid Functions and Progression-Free Survival during First-Line Chemotherapy in Advanced Non-small Cell Lung Cancer

Pathology oncology research, 2020-04, Vol.26 (2), p.1117-1128

2020

Volltextzugriff (PDF)

Durvalumab, with or without tremelimumab, plus platinum–etoposide versus platinum–etoposide alone in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): updated results from a randomised, controlled, open-label, phase 3 trial

The lancet oncology, 2021-01, Vol.22 (1), p.51-65

2021

Volltextzugriff (PDF)

Soluble Urokinase-Type Plasminogen Activator Receptor and Arterial Stiffness in Patients with COPD

Lung, 2019-04, Vol.197 (2), p.189-197

2019

Volltextzugriff (PDF)

Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC

The New England journal of medicine, 2018-12, Vol.379 (24), p.2342-2350

2018

Volltextzugriff (PDF)

Exhaled breath temperature in patients with stable and exacerbated COPD

Journal of breath research, 2014-12, Vol.8 (4), p.046002-046002

2014

Volltextzugriff (PDF)

Durvalumab after Chemoradiotherapy in Stage III Non–Small-Cell Lung Cancer

The New England journal of medicine, 2017-11, Vol.377 (20), p.1919-1929

2017

Volltextzugriff (PDF)

Decreased ERCC1 Expression After Platinum-Based Neoadjuvant Chemotherapy in non-Small Cell Lung Cancer

Pathology oncology research, 2015-04, Vol.21 (2), p.423-431

2015

Volltextzugriff (PDF)

Gefitinib treatment in lung cancer -- rebiopsy, retreatment, remission

Magyar onkologia, 2014-06, Vol.58 (2), p.133

2014

Volltextzugriff (PDF)

Non-invasive respiratory unit in the Hungarian health care system

Orvosi hetilap, 2012-06, Vol.153 (23), p.918-921

2012

Volltextzugriff (PDF)

Evening and morning exhaled volatile compound patterns are different in obstructive sleep apnoea assessed with electronic nose

Sleep & breathing, 2015-03, Vol.19 (1), p.247-253

2015

Volltextzugriff (PDF)

Association Between Serum Lipid Profile and Obstructive Respiratory Events During REM and Non-REM Sleep

Lung, 2019-08, Vol.197 (4), p.443-450

2019

Volltextzugriff (PDF)

Expiratory flow rate, breath hold and anatomic dead space influence electronic nose ability to detect lung cancer

BMC pulmonary medicine, 2014-12, Vol.14 (1), p.202-202, Article 202

2014

Volltextzugriff (PDF)

Platinum-Based Chemotherapy in Lung Cancer Affects the Expression of Certain Biomarkers Including ERCC1

Pathology oncology research, 2009-09, Vol.15 (3), p.445-450

2009

Volltextzugriff (PDF)

Examination of ERCC1 expression in lung cancer patients treated with platinum-based chemotherapy

Magyar onkologia, 2011-06, Vol.55 (2), p.105

2011

Volltextzugriff (PDF)

Overnight Changes in Lung Function of Obese Patients with Obstructive Sleep Apnoea

Lung, 2017-02, Vol.195 (1), p.127-133

2017

Volltextzugriff (PDF)

Exhaled Breath Condensate pH in Lung Cancer, the Impact of Clinical Factors

Lung, 2015-12, Vol.193 (6), p.957-963

2015

Volltextzugriff (PDF)

1 – 25 von 34

Suche als RSS-Feed

Aktive Filter

ThemaAged

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(32)
Mit Volltextzugriff
(24)

Publikationsform

Artikel
(34)

Sprache

Englisch
(28)
Ungarisch
(6)

Erscheinungsjahr

n.n

Thema

Humans
(34)
Female
(33)
Middle Aged
(33)
Male
(32)
Life Sciences & Biomedicine
(25)
Science & Technology
(25)
Adult
(22)
Oncology
(14)
Lung Neoplasms - Drug Therapy
(13)
Lung Cancer
(11)
Lung Neoplasms - Mortality
(11)
Respiratory System
(11)
Aged, 80 And Over
(8)
Cancer Therapies
(8)
Chemotherapy
(8)
Lung Neoplasms - Pathology
(8)
Neoplasm Staging
(8)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(7)
Case-Control Studies
(7)

14 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Randomized Phase III Placebo-Controlled Trial of Carboplatin and Paclitaxel With or Without the Vascular Disrupting Agent Vadimezan (ASA404) in Advanced Non–Small-Cell Lung Cancer

Dysregulation of the endothelial nitric oxide pathway is associated with airway inflammation in COPD

Necitumumab plus gemcitabine and cisplatin versus gemcitabine and cisplatin alone as first-line therapy in patients with stage IV squamous non-small-cell lung cancer (SQUIRE): an open-label, randomised, controlled phase 3 trial

Asthma control in patients receiving inhaled corticosteroid and long-acting beta2-agonist fixed combinations. A real-life study comparing dry powder inhalers and a pressurized metered dose inhaler extrafine formulation

Necitumumab plus pemetrexed and cisplatin as first-line therapy in patients with stage IV non-squamous non-small-cell lung cancer (INSPIRE): an open-label, randomised, controlled phase 3 study

Airway dynamics in COPD patients by within-breath impedance tracking: effects of continuous positive airway pressure

TG4010 immunotherapy and first-line chemotherapy for advanced non-small-cell lung cancer (TIME): results from the phase 2b part of a randomised, double-blind, placebo-controlled, phase 2b/3 trial

Five-year survival in patients with extensive-stage small cell lung cancer treated with atezolizumab in the Phase III IMpower133 study and the Phase III IMbrella A extension study

Durvalumab plus platinum–etoposide versus platinum–etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): a randomised, controlled, open-label, phase 3 trial

Effect of COPD on Inflammation, Lymphoid Functions and Progression-Free Survival during First-Line Chemotherapy in Advanced Non-small Cell Lung Cancer

Durvalumab, with or without tremelimumab, plus platinum–etoposide versus platinum–etoposide alone in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): updated results from a randomised, controlled, open-label, phase 3 trial

Soluble Urokinase-Type Plasminogen Activator Receptor and Arterial Stiffness in Patients with COPD

Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC

Exhaled breath temperature in patients with stable and exacerbated COPD

Durvalumab after Chemoradiotherapy in Stage III Non–Small-Cell Lung Cancer

Decreased ERCC1 Expression After Platinum-Based Neoadjuvant Chemotherapy in non-Small Cell Lung Cancer

Gefitinib treatment in lung cancer -- rebiopsy, retreatment, remission

Non-invasive respiratory unit in the Hungarian health care system

Evening and morning exhaled volatile compound patterns are different in obstructive sleep apnoea assessed with electronic nose

Association Between Serum Lipid Profile and Obstructive Respiratory Events During REM and Non-REM Sleep

Expiratory flow rate, breath hold and anatomic dead space influence electronic nose ability to detect lung cancer

Platinum-Based Chemotherapy in Lung Cancer Affects the Expression of Certain Biomarkers Including ERCC1

Examination of ERCC1 expression in lung cancer patients treated with platinum-based chemotherapy

Overnight Changes in Lung Function of Obese Patients with Obstructive Sleep Apnoea

Exhaled Breath Condensate pH in Lung Cancer, the Impact of Clinical Factors

Aktive Filter

Suchergebnisse filtern